Detection and alterations of acetylcarnitine (AC) in human liver by H-1 MRS at 3T after supplementation with l-carnitine

PurposeAcetylcarnitine can be assessed in vivo using proton MRS (H-1-MRS) with long TEs and this has been previously applied successfully in muscle. The aim of this study was to evaluate a H-1-MRS technique for liver acetylcarnitine quantification in healthy humans before and after l-carnitine supplementation. MethodBaseline acetylcarnitine levels were quantified using a STEAM sequence with prolonged TE in 15 healthy adults. Using STEAM with four different TEs was evaluated in phantoms. To assess reproducibility of the measurements, five of the participants had repeated H-1-MRS without receiving l-carnitine supplementation. To determine if liver acetylcarnitine could be changed after l-carnitine supplementation, acetylcarnitine was quantified 2 h after intravenous l-carnitine supplementation (50 mg/kg body weight) in the other 10 participants. Hepatic lipids were also quantified from the H-1-MRS spectra. ResultsThere was good separation between the acetylcarnitine and fat in the phantoms using TE = 100 ms. Hepatic acetylcarnitine levels were reproducible (coefficient of reproducibility = 0.049%) and there was a significant (p < 0.001) increase in the relative abundance after a single supplementation of l-carnitine. Hepatic allylic, methyl, and methylene peaks were not altered by l-carnitine supplementation in healthy volunteers. ConclusionOur results demonstrate that our H-1-MRS technique could be used to measure acetylcarnitine in the liver and detect changes following intravenous supplementation in healthy adults despite the presence of lipids. Our techniques should be explored further in the study of fatty liver disease, where acetylcarnitine is suggested to be altered due to hepatic inflexibilities.